These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7030443)

  • 41. Correlation between plasma chlorpromazine and its metabolites and clinical ratings in patients with acute relapse of schizophrenic and paranoid psychosis.
    Phillipson OT; McKeown JM; Baker J; Healey AF
    Br J Psychiatry; 1977 Aug; 131():172-84. PubMed ID: 912219
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlation between plasma concentrations of chlorpromazine and clinical response.
    Rivera-Calimlim L; Gift T; Nasrallah HA; Wyatt RJ; Lasagna L
    Commun Psychopharmacol; 1978; 2(3):215-22. PubMed ID: 699536
    [No Abstract]   [Full Text] [Related]  

  • 43. A longitudinal therapeutic comparison between two prototypic neuroleptics (haloperidol and chlorpromazine) in matched groups of schizophrenics. Nontherapeutic interactions with trihexyphenidyl. Theoretical implications for potency differences.
    Singh MM; Kay SR
    Psychopharmacologia; 1975 Aug; 43(2):115-21. PubMed ID: 1103206
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum neuroleptic levels, prolactin levels, and relapse: a two-year study of schizophrenic outpatients.
    Faraone SV; Brown WA; Laughren TP
    J Clin Psychiatry; 1987 Apr; 48(4):151-4. PubMed ID: 2881923
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dose dependent changes in propranolol half life when used as an adjunct to neuroleptic treatment.
    Staniforth DH; Yorkston NJ; Zaki SA
    Psychopharmacology (Berl); 1982; 76(1):62-5. PubMed ID: 6123130
    [No Abstract]   [Full Text] [Related]  

  • 46. Propranolol in schizophrenia: a double blind, placebo controlled trial of propranolol as an adjunct to neuroleptic medication.
    Pugh CR; Steinert J; Priest RG
    Br J Psychiatry; 1983 Aug; 143():151-5. PubMed ID: 6137255
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of diazepam alone and in combination with chlorpromazine or propranolol in the therapy of tetanus.
    Billimoria RB; Chhabra RH; Satoskar RS
    J Postgrad Med; 1981 Apr; 27(2):80-5. PubMed ID: 7277252
    [No Abstract]   [Full Text] [Related]  

  • 48. The risks and benefits of clozapine versus chlorpromazine.
    Claghorn J; Honigfeld G; Abuzzahab FS; Wang R; Steinbook R; Tuason V; Klerman G
    J Clin Psychopharmacol; 1987 Dec; 7(6):377-84. PubMed ID: 3323261
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of pimozide and chlorpromazine in acute schizophrenia.
    Pecknold JC; McClure DJ; Allan T; Wrzesinski L
    Can J Psychiatry; 1982 Apr; 27(3):208-12. PubMed ID: 7046898
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum prolactin levels following intramuscular chlorpromazine: two- and three-hour response as predictors of six-hour response.
    Busch DA; Fang VS; Meltzer HY
    Psychiatry Res; 1979 Oct; 1(2):153-9. PubMed ID: 45130
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of antiparkinsonian medication on plasma levels of chlorpromazine.
    Simpson GM; Cooper TB; Bark N; Sud I; Lee JH
    Arch Gen Psychiatry; 1980 Feb; 37(2):205-8. PubMed ID: 7352851
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of clozapine on human serum prolactin levels.
    Meltzer HY; Goode DJ; Schyve PM; Young M; Fang VS
    Am J Psychiatry; 1979 Dec; 136(12):1550-5. PubMed ID: 507205
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clotiapine compared with chlorpromazine in chronic schizophrenia.
    Geller V; Gorzaltsan I; Shleifer T; Belmaker RH; Bersudsky Y
    Schizophr Res; 2005 Dec; 80(2-3):343-7. PubMed ID: 16126373
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma prolactin levels before and during propranolol treatment in chronic schizophrenia.
    Wilson JD; King DJ; Sheridan B
    Br J Clin Pharmacol; 1979 Mar; 7(3):313-4. PubMed ID: 427008
    [No Abstract]   [Full Text] [Related]  

  • 55. Prediction of response to and actual outcome of chlorpromazine treatment in schizophrenic patients.
    Sakurai Y; Takahashi R; Nakahara T; Ikenaga H
    Arch Gen Psychiatry; 1980 Sep; 37(9):1057-62. PubMed ID: 7416905
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A double blind comparison of thiothixene and a trifluoperazine/chlorpromazine composite in the treatment of chronic schizophrenia.
    Knight RG; Harrison A
    N Z Med J; 1979 Apr; 89(634):302-4. PubMed ID: 377155
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical effects of L-5-hydroxytryptophan administration in chronic schizophrenic patients.
    Bigelow LB; Walls P; Gillin JC; Wyatt RJ
    Biol Psychiatry; 1979 Feb; 14(1):53-67. PubMed ID: 369623
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does propranolol have an antipsychotic effect? A placebo-controlled study in acute schizophrenia.
    Manchanda R; Hirsch SR
    Br J Psychiatry; 1986 Jun; 148():701-7. PubMed ID: 2877702
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Variability of response to neuroleptics in schizophrenia: clinical, pharmacologic, and neuroendocrine correlates.
    Gelder M; Kolakowska T
    Compr Psychiatry; 1979; 20(5):397-408. PubMed ID: 39704
    [No Abstract]   [Full Text] [Related]  

  • 60. Dopamine antagonism by thioridazine in schizophrenia.
    Meltzer HY; Sachar EJ; Frantz AG
    Biol Psychiatry; 1975 Feb; 10(1):53-7. PubMed ID: 1120175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.